186 related articles for article (PubMed ID: 38287441)
21. PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis.
Schade B; Rao T; Dourdin N; Lesurf R; Hallett M; Cardiff RD; Muller WJ
J Biol Chem; 2009 Jul; 284(28):19018-26. PubMed ID: 19435886
[TBL] [Abstract][Full Text] [Related]
22. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
[TBL] [Abstract][Full Text] [Related]
23. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.
Fereshteh MP; Tilli MT; Kim SE; Xu J; O'Malley BW; Wellstein A; Furth PA; Riegel AT
Cancer Res; 2008 May; 68(10):3697-706. PubMed ID: 18483252
[TBL] [Abstract][Full Text] [Related]
24. Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models.
Devarajan R; Izzi V; Peltoketo H; Rask G; Kauppila S; Väisänen MR; Ruotsalainen H; Martínez-Nieto G; Karppinen SM; Väisänen T; Kaur I; Koivunen J; Sasaki T; Winqvist R; Manninen A; Wärnberg F; Sund M; Pihlajaniemi T; Heljasvaara R
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37498672
[TBL] [Abstract][Full Text] [Related]
25. The LIM domain binding protein 1, Ldb1, has distinct roles in Neu-induced mammary tumorigenesis.
Ahmed S; Pryce BR; Al-Zahrani KN; Sabourin LA
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt A):1590-1597. PubMed ID: 30327200
[TBL] [Abstract][Full Text] [Related]
26. ErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasis.
Xu M; Ren Z; Wang X; Comer A; Frank JA; Ke ZJ; Huang Y; Zhang Z; Shi X; Wang S; Luo J
Mol Cancer; 2016 Jul; 15(1):52. PubMed ID: 27416801
[TBL] [Abstract][Full Text] [Related]
27. HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis.
Tekmal RR; Nair HB; Perla RP; Kirma N
J Steroid Biochem Mol Biol; 2007; 106(1-5):111-8. PubMed ID: 17604617
[TBL] [Abstract][Full Text] [Related]
28. CX3CL1 promotes breast cancer via transactivation of the EGF pathway.
Tardáguila M; Mira E; García-Cabezas MA; Feijoo AM; Quintela-Fandino M; Azcoitia I; Lira SA; Mañes S
Cancer Res; 2013 Jul; 73(14):4461-73. PubMed ID: 23720051
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis.
Croci S; Nanni P; Palladini A; Nicoletti G; Grosso V; Benegiamo G; Landuzzi L; Lamolinara A; Ianzano ML; Ranieri D; Dall'Ora M; Iezzi M; De Giovanni C; Lollini PL
Breast Cancer Res; 2015 May; 17(1):70. PubMed ID: 25997501
[TBL] [Abstract][Full Text] [Related]
30. Hunk is required for HER2/neu-induced mammary tumorigenesis.
Yeh ES; Yang TW; Jung JJ; Gardner HP; Cardiff RD; Chodosh LA
J Clin Invest; 2011 Mar; 121(3):866-79. PubMed ID: 21393859
[TBL] [Abstract][Full Text] [Related]
31. Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer.
Farabaugh SM; Chan BT; Cui X; Dearth RK; Lee AV
Cell Commun Signal; 2016 Oct; 14(1):25. PubMed ID: 27765041
[TBL] [Abstract][Full Text] [Related]
32. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
33. Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression.
Zambrano JN; Neely BA; Yeh ES
Pharmacol Res; 2017 May; 119():188-194. PubMed ID: 28189783
[TBL] [Abstract][Full Text] [Related]
34. ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss.
Lozy F; Cai-McRae X; Teplova I; Price S; Reddy A; Bhanot G; Ganesan S; Vazquez A; Karantza V
Autophagy; 2014 Apr; 10(4):662-76. PubMed ID: 24492513
[TBL] [Abstract][Full Text] [Related]
35. Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.
Deng X; Li Q; Hoff J; Novak M; Yang H; Jin H; Erfani SF; Sharma C; Zhou P; Rabinovitz I; Sonnenberg A; Yi Y; Zhou P; Stipp CS; Kaetzel DM; Hemler ME; Yang XH
Neoplasia; 2012 Aug; 14(8):678-89. PubMed ID: 22952421
[TBL] [Abstract][Full Text] [Related]
36. Mutant p53 Amplifies Epidermal Growth Factor Receptor Family Signaling to Promote Mammary Tumorigenesis.
Yallowitz AR; Li D; Lobko A; Mott D; Nemajerova A; Marchenko N
Mol Cancer Res; 2015 Apr; 13(4):743-54. PubMed ID: 25573952
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis.
Mancini ML; Lien EC; Toker A
Oncotarget; 2016 Apr; 7(14):17301-13. PubMed ID: 27004402
[TBL] [Abstract][Full Text] [Related]
38. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
Fry EA; Taneja P; Inoue K
Int J Cancer; 2017 Feb; 140(3):495-503. PubMed ID: 27553713
[TBL] [Abstract][Full Text] [Related]
40. Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice.
Jenkins S; Wang J; Eltoum I; Desmond R; Lamartiniere CA
Environ Health Perspect; 2011 Nov; 119(11):1604-9. PubMed ID: 21988766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
